Analystreport

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Jonestrading. They set a "buy" rating on the stock.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report